Работы, цитирующие эту работу

Работ: 4

Работа: Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

1. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2019.article.000020

2. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

   Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

   СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.262608

3. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   СтатьяTuberculosis Research and EpidemiologyERJ Open Research2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.360284

4. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   СтатьяTuberculosis Research and EpidemiologyPLoS ONE2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.360285